BUYSE, Marc

Email Alert RSS Feed

Profile

Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 1-20 of 216 (Search time: 0.016 seconds).

show all
Issue DateTitleContributor(s)TypeCat.
12025From non-inferiority to superiority: the shift towards patient-centric outcomesVERBEECK, Johan; De Backer, Mickael; BUYSE, MarcJournal ContributionA2
22025Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized TrialsRavi, Praful; Xie, Wanling; BUYSE, Marc; Halabi, Susan; Kantoff, Philip W.; Sartor, Oliver; Attard, Gert; Clarke, Noel; D'Amico, Anthony; Dignam, James; James, Nicholas; Fizazi, Karim; Gillessen, Silke; Parulekar, Wendy; Sandler, Howard; Spratt, Daniel E.; Sydes, Matthew R.; Tombal, Bertrand; Williams, Scott; Sweeney, Christopher J.Journal ContributionA1
32025Detection of Outlying Correlation Coefficients in Multicenter Clinical TrialsDesmet, Lieven; Venet, David; Trotta, Laura; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
42025Generalized Pairwise Comparisons to Support Shared Decision-Making in the CODA TrialSalvaggio, Samuel; Monsell, Sarah E.; Heagerty, Patrick J.; De Backer, Mickael; Barre, Emilie; Chiem, Jean-Christophe; Saad, Everardo D.; BUYSE, Marc; Flum, David R.Journal ContributionA1
52024The tyranny of non-inferiority trialsTannock, Ian F.; BUYSE, Marc; De Backer, Mickael; Earl, Helena; Goldstein, Daniel A.; Ratain, Mark; Saltz, Leonard B.; Sonke, Gabe S.; Strohbehn, Garth W.Journal ContributionA1
62024Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data AvailabilityModi, Natansh D.; Swain, Sandra M.; BUYSE, Marc; Kuderer, Nicole M.; Rowland, Andrew; Rockhold, Frank W.; Sorich, Michael J.; Hopkins, Ashley M.Journal ContributionA2
72024Acoramidis in Transthyretin Amyloid CardiomyopathyVERBEECK, Johan; De Backer, Mickael; BUYSE, MarcJournal ContributionA1
82024Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical Trialsde Viron, Sylviane; Trotta, Laura; Steijn, William; Young, Steve; BUYSE, MarcJournal ContributionA1
92024Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimenBacker, MD; Sengar, M; Mathews, V; Salvaggio, S; DELTUVAITE-THOMAS, Vaiva; Chiem, JC; Saad, ED; BUYSE, MarcJournal ContributionA1
102024End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?Degtyarev, Evgeny; Bolanos, Natacha; Brody, Joshua D.; Buchbinder, Aby; BUYSE, Marc; Fuchs, Miriam; Halabi, Susan; Hemmings, Robert; Masood, Aisha; Newsome, Simon; Saxton, Claire; Warwick, Lorna; Yateman, Nigel A.; Zuber, EmmanuelJournal ContributionA1
112024Challenges and Opportunities in Establishing Appropriate Intermediate Endpoints Reflecting Patient Benefit: A Roadmap for Research and Clinical Application in Nonmetastatic Prostate CancerBrookman-May, Sabine D.; BUYSE, Marc; Freedland, Stephen J.; Miladinovic, Branko; Zhang, Ke; Fendler, Wolfgang P.; Feng, Felix; Sartor, Oliver; Sweeney, Christopher J.Journal ContributionA2
122024Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy RevisitedFokas, Emmanouil; Smith, J. Joshua; Garcia-Aguilar, Julio; Glynne-Jones, Robert; BUYSE, Marc; Roedel, ClausJournal ContributionA2
132024Restricted Net Treatment Benefit in oncologyPiffoux, Max; Ozenne, Brice; De Backer, Mickael; BUYSE, Marc; Chiem, Jean-Christophe; Peron, JulienJournal ContributionA1
142024Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancerXie, W; Ravi, P; BUYSE, Marc; Halabi, S; Kantoff, P; Sartor, O; Soule, H; Clarke, N; Dignam, J; James, N; Fizazi, K; Gillessen, S; Mottet, N; Murphy , L; Parulekar, W; Sandler, H; Tombal, B; Williams, S; Sweeney, CJJournal ContributionA1
152023Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 TherapySquifflet, Pierre D.; Saad, Everardo; Loibl, Sibylle T.; van Mackelenbergh, Marion; Untch, Michael; Rastogi, Priya; Gianni, Luca; Schneeweiss, Andreas; Conte, Pierfranco; Piccart, Martine; Bonnefoi, Herve; Jackisch, Christian; Nekljudova, Valentina; Tang, Gong; Valagussa, Pinuccia; Neate, Colin; Gelber, Richard; Poncet, Coralie; Heinzmann, Dominik; Denkert, Carsten E.; Geyer Jr, Charles; Cortes, Javier; Guarneri, Valentina; de Azambuja, Evandro; Cameron, David; Ismael, Gustavo; Wolmark, Norman; Cortazar, Patricia; BUYSE, Marc; CTNeoBC ProjectJournal ContributionA1
162023Including patient relevant endpoints (quality of life) in multicomponent endpoints with generalized pairwise comparisonsVERBEECK, Johan; De, Backer M.; Barre, E.; Salvaggio, S.; DELTUVAITE-THOMAS, Vaiva; Chiem, J. C.; Kosta, S.; BUYSE, MarcJournal ContributionM
172023Highlighting the multidimensional benefits of a drug using generalized pairwise comparisonsChiem, J. C.; Saad, E.; De Backer, M.; Salvaggio, S.; Kosta, S.; Barre, E.; DELTUVAITE-THOMAS, Vaiva; VERBEECK, Johan; BUYSE, MarcJournal ContributionM
182023Trial Design for Cancer Immunotherapy: A Methodological ToolkitSaad, Everardo D.; Coart, Elisabeth; DELTUVAITE-THOMAS, Vaiva; GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
192023On Enhancing Clinical Trial Data SharingBUYSE, MarcJournal ContributionA2
202023Generalized pairwise comparisons of prioritized outcomes are a powerful and patient-centric analysis of multi-domain scoresDELTUVAITE-THOMAS, Vaiva; De Backer, Mickael; Parker, Samantha; Deneux, Marie; Polgreen, Lynda E.; O'Neill, Cara; Salvaggio, Samuel; BUYSE, MarcJournal ContributionA1
show all